| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Oncology, Hadassah University Hospital, Jerusalem, Israel [M. B., I. V., R. B-S.]; Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel [A. Y.]; Department of Medicinal Chemistry, Rhone-Poulenc Rorer Central Research, King of Prussia, Pennsylvania [J. R., M. C.]; and The Hubert H. Humphrey Center for Experimental Medicine and Cancer Research, the Hebrew University-Hadassah Medical School, Jerusalem, Israel [S. B-S.]
NIH-3T3 cells transfected with basic fibroblast growth factor (bFGF) fused to a signal peptide sequence (spbFGF cells) are transformed in vitro and tumorigenic in vivo. Treatment of spbFGF cells with low and nontoxic concentrations (0.52.5 µg/ml) of negatively charged, nonsulfated aromatic compounds (e.g., aurin tricarboxylic acid, 4-hydroxyphenoxyacetic acid) resulted in restoration of their normal proliferative rate, morphological appearance, and adhesion properties. Binding and cross-linking experiments using 125I-labeled bFGF revealed that these alterations were associated with an up-regulation of high affinity receptors for bFGF on the cell surface. A similar up-regulation of cross-linkable bFGF receptors was induced by these compounds in spbFGF cells that were seeded on fibronectin to enforce a firm cell attachment and flattening. Thus, induction of spbFGF cell adhesion and spreading may not be related to restoration of normal bFGF-receptor interactions. Although the negatively charged aromatic compounds mimic many of the effects of heparin in other systems (e.g., release of heparin- and heparan sulfate-bound proteins, inhibition of heparanase), heparin, heparan sulfate, and dextran sulfate were not effective at the low concentrations of the anionic compounds used in the present study. Likewise, suramin, a sulfated aromatic molecule, was effective at toxic concentrations, 400600-fold higher than the nonsulfated aromatic compounds. The development of defined, nontoxic anionic compounds may provide a new strategy to interfere with the autonomous and anchorage independent mode of cell growth involved in autocrine cell transformation and cancer.
1 This work was supported by USPHS Grant CA-30289 awarded to I. V. by the National Cancer Institute, Department of Health and Human Services, and by a grant from Rhone-Poulenc Rorer Pharmaceuticals, Inc.
2 To whom requests for reprints should be addressed, at Department of Oncology, Hadassah Hospital, P.O. Box 12000, Jerusalem 91120, Israel.
Received 4/ 8/92. Accepted 8/ 3/92.
This article has been cited by other articles:
![]() |
B. Medalion, G. Merin, H. Aingorn, H.-Q. Miao, A. Nagler, A. Elami, R. Ishai-Michaeli, and I. Vlodavsky Endogenous Basic Fibroblast Growth Factor Displaced by Heparin From the Lumenal Surface of Human Blood Vessels Is Preferentially Sequestered by Injured Regions of the Vessel Wall Circulation, April 1, 1997; 95(7): 1853 - 1862. [Abstract] [Full Text] |
||||
![]() |
J. R. Regan, J. G. Bruno, M. N. Chang, R. Sabatino, R. D'Alisa, S. A. Ben-Sasson, and D. Eilat Mimicry of Biological Macromolecules by Polyaromatic Anionic Compounds Journal of Bioactive and Compatible Polymers, January 1, 1993; 8(4): 317 - 337. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |